CancerNetwork Members: Login | Register
 
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
PATIENTS
NURSES
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NURSES

ONCOLOGY Nurse Edition. Vol. 24 No. 2
Pages: 1  2  3  4  5  6  7  8  9  
Next
 

Integrating Genetics and Genomics Into Oncology Nursing

By Dale Halsey Lea, MPH, RN, CGC, FAAN
Health Educator, National Human
Genome Research Institute

Kathleen A. Calzone, MSN, RN, APNG, FAAN
Senior Nurse Specialist, Research, National Cancer
Institute, Center for Cancer Research—Genetics Branch

National Institutes of Health, Bethesda, Maryland | February 16, 2010

Abstract Genetic and genomic research discoveries are ushering in a new era of healthcare—personalized healthcare, which can potentially transform healthcare through earlier diagnosis and more effective risk assessment and cancer risk management. It may also inform optimal drug selection and limit drug side effects. This has important implications for oncology nursing practice throughout the cancer care continuum. In recognition of the expanding role of genetics and genomics in nursing practice, the Essentials of Genetic and Genomic Nursing was first published in 2006 by an independent consensus panel of nursing professionals. This resource is now in its second edition. As the consensus panel notes, genetic and genomic information will be utilized increasingly for prevention, screening, diagnosis, assessment of prognosis, selection of treatment, and monitoring of disease. This article, founded on the Essentials of Genetic and Genomic Nursing, describes the integration of genetics and genomics into oncology nursing practice, highlighting ways that new information and understanding in this area have advanced the management of patients at risk for or diagnosed with cancer.

Click here to link to the CME post-test for this article.


Genetic and genomic research is creating new and more individualized approaches to better manage a person's disease or predisposition to disease, including cancer. This approach to healthcare is called personalized healthcare.[1] These discoveries have important implications for oncology nursing practice throughout the cancer care continuum. This continuum encompasses primary prevention, screening, diagnosis, treatment, survivorship, recurrence, and progression through the end of life.[2] In recognition of the expanding role of genetics and genomics in nursing practice, the Essentials of Genetic and Genomic Nursing was first published in 2006 by an independent consensus panel of nursing professionals. It is now in its second edition.[3] Using the Essentials of Genetic and Genomic Nursing as a basis, this article provides an overview of where and how oncology nurses will be or already are integrating genetics, genomics, and personalized healthcare into their daily practice.

Genetic/Genomic Research and Understanding Cancer

In 2003, an international research effort to sequence the entire genome of human beings, called the Human Genome Project (HGP), was completed. The completion of the HGP has opened doors for scientists to understand more about the role of genes in health and disease.[4] Genes, units of hereditary information located at specific positions in a chromosome, code for proteins that contribute to particular characteristics or functions. For example, genes play a role in 9 of the 10 leading causes of death in the United States, including cancer.[4]

Genetics investigations have traditionally involved assessment of how single genes influence relatively rare, single-gene disorders. Studies of the human genome are leading to greater knowledge of the ways in which genes interact with each other and with the environment, helping to improve health and prevent disease.[5] This new focus of research, genomics, involves all genes in the human genome and their interactions with each other, the environment, and cultural and psychosocial factors.[6] Table 1 provides more information and resources on genetics and genomics, and their roles in health and disease.

One approach to learning about the genetics of common, complex disorders is known as a genome-wide association study (GWAS). A GWAS uses rapidly scanning markers across the genomes of many people to identify genetic variations that are associated with a specific disease. The GWAS allows scientists to find the common genetic changes that contribute to small increases in disease risk.[7] When the genetic associations are located, researchers can use the information to develop better ways to prevent, diagnose, and treat disease. GWAS approaches have been very helpful in finding genetic variations that contribute to common, complex diseases such as diabetes, heart disease, mental illness, and cancer.

Pages: 1  2  3  4  5  6  7  8  9  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

  • Bladder Cancer
  • Bone Metastases
  • Breast Cancer
  • CML
  • Colorectal Cancer
  • End-of-Life
  • GIST
  • Genetics Genomics
  • Gynecologic Cancers
  • Head & Neck Cancer
  • Integrative Oncology
  • Leukemia
  • Lung Cancer
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Nausea & Vomiting
  • Palliative Care
  • Pancreatic Cancer
  • Practice Management
  • Practice & Policy
  • Prostate Cancer
  • RCC
  • Skin Cancer
  • Triple-Negative Breast
  • Testicular Cancer


More Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
'What They Should Really Teach in Medical School'
Julie Schopps, MD , February 6, 2012
The North Carolina-based pediatrician weighs in on why she thinks the real learning doesn't take place until students are out of the classroom.
Improve EHR Systems by Rethinking Medical Billing
Daniel Essin, MA, MD, February 6, 2012
Separating billing-related data from other clinical documentation and transmitting it to a billing system is not difficult …no matter how the charting is done.
Keeping Your Medical Practice’s Accounts Receivable on Track
P.J. Cloud-Moulds, February 4, 2012
Here are the minimum reports you should be running to keep an eye on your practices A/R.
Healthcare Providers Play Crucial Role in Helping Victims of Abuse
Stephen Hanson, PA-C , February 3, 2012
I would urge each and every one of you to be familiar with the warning signs of abuse, and the resources available to you all as healthcare providers.
Protecting Your Medical Practice's Data
Marisa Torrieri, February 3, 2012
Here's the scoop on how to implement a good data-backup plan at your office.
 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Management of Brain Metastases: Neurosurgical Considerations
  • Head and Neck Tumors
  • Optimizing Outcomes of Advanced Prostate Cancer: Drug Sequencing and Novel Therapeutic Approaches
  • A 28-Year-Old Woman Presents With a Long-Standing History of Intermittently Painful “Bumps” on Both Her Shoulders and Upper Back
  • Controversies in Oncologist-Patient Communication: A Nuanced Approach to Autonomy, Culture, and Paternalism
  • Ending the Shortage of Generic Oncology Drugs
  • Processed and Red Meat Consumption Linked to Slight Increase in Risk of Pancreatic Cancer
  • Younger Breast Cancer Patients Have More Adverse Quality of Life Issues
  • Controversies in Oncologist-Patient Communication: A Nuanced Approach to Autonomy, Culture, and Paternalism
  • Could Aspirin Be a Viable Adjuvant Treatment for Cancer?
  • AL Amyloidosis: Who, What, When, Why, and Where
  • The Maze of PARP Inhibitors in Ovarian Cancer
  • The Circuitous Path of PARP Inhibitor Development in Epithelial Ovarian Cancer
  • Podcast: Dr. David Ahlquist on Advances in Colorectal Cancer Screening
  • Lung Cancer Screening: A New Era
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • When to Treat Myelodysplastic Syndromes
  • ASCO 2011: A Paradigm Shift in the Treatment of Endometrial Cancer
  • PSA Screening for Prostate Cancer Put Into Question By the U.S. Preventive Services Task Force
  • PSA Screening for Prostate Cancer Put Into Question By the U.S. Preventive Services Task Force
  • When to Treat Myelodysplastic Syndromes
  • ASCO 2011: A Paradigm Shift in the Treatment of Endometrial Cancer
  • Are We Ready for Neoadjuvant Therapy in Potentially Resectable Pancreatic Cancer?
  • Evolving Therapeutic Paradigms for Advanced Prostate Cancer
Click here to subscribe to our newsletter
 
JOB LISTINGS

Post a job

Powered by SearchMedica Jobs



CancerNetwork on Facebook

 

 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Oncology Nursing
Evidence on Oncology Nursing
Guidelines on Oncology Nursing
Patient Education on Oncology Nursing
Clinical Trials on Oncology Nursing
Practical Articles on Oncology Nursing
Research and Reviews on Oncology Nursing
All "Oncology Nursing" results

CancerNetwork | CME LLC | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2012 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy